Healthcare provider profile · identity verified

Benjamin Moss, PA-C

Physician Assistant · GRANTS PASS, OR · NPI 1134453418

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	417	132
Levothyroxine Sodium	Levothyroxine Sodium	349	95
Losartan Potassium	Losartan Potassium	299	104
Amlodipine Besylate	Amlodipine Besylate	298	90
Metoprolol Succinate	Metoprolol Succinate	270	88
Potassium Chloride	Potassium Chloride	223	72
Gabapentin	Gabapentin	215	59
Lisinopril	Lisinopril	203	73
Furosemide	Furosemide	184	61
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	157	50
Metformin Hcl	Metformin Hcl	154	53
Omeprazole	Omeprazole	139	49
Tamsulosin Hcl	Tamsulosin Hcl	127	48
Hydrochlorothiazide	Hydrochlorothiazide	124	43
Eliquis	Apixaban	115	30
Celecoxib	Celecoxib	105	31
Albuterol Sulfate Hfa	Albuterol Sulfate	92	61
Baclofen	Baclofen	88	32
Tramadol Hcl	Tramadol Hcl	81	25
Simvastatin	Simvastatin	79	28
Donepezil Hcl	Donepezil Hcl	74	22
Trazodone Hcl	Trazodone Hcl	72	24
Escitalopram Oxalate	Escitalopram Oxalate	68	17
Prednisone	Prednisone	68	50
Pantoprazole Sodium	Pantoprazole Sodium	67	27
Pravastatin Sodium	Pravastatin Sodium	64	17
Metoprolol Tartrate	Metoprolol Tartrate	63	25
Carvedilol	Carvedilol	58	21
Finasteride	Finasteride	56	17
Zolpidem Tartrate	Zolpidem Tartrate	56	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	55	16
Rosuvastatin Calcium	Rosuvastatin Calcium	55	27
Alprazolam	Alprazolam	54	11
Duloxetine Hcl	Duloxetine Hcl	52	16
Montelukast Sodium	Montelukast Sodium	52	13
Sertraline Hcl	Sertraline Hcl	52	15
Doxazosin Mesylate	Doxazosin Mesylate	50	17
Lorazepam	Lorazepam	50	13
Pioglitazone Hcl	Pioglitazone Hcl	47	15
Allopurinol	Allopurinol	44	15
Atenolol	Atenolol	44	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	43	13
Xarelto	Rivaroxaban	42	12
Warfarin Sodium	Warfarin Sodium	41	13
Glipizide	Glipizide	39	13
Propranolol Hcl	Propranolol Hcl	39	suppressed
Spironolactone	Spironolactone	39	11
Alendronate Sodium	Alendronate Sodium	37	15
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	36	suppressed
Oxycodone Hcl	Oxycodone Hcl	35	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	35	suppressed
Estradiol	Estradiol	34	15
Ozempic	Semaglutide	34	suppressed
Valsartan	Valsartan	34	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	30
Valacyclovir	Valacyclovir Hcl	33	12
Citalopram Hbr	Citalopram Hydrobromide	32	11
Fluoxetine Hcl	Fluoxetine Hcl	32	11
Bupropion Xl	Bupropion Hcl	31	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Clopidogrel	Clopidogrel Bisulfate	29	12
Pregabalin	Pregabalin	27	suppressed
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	18
Cefdinir	Cefdinir	24	18
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Colchicine	Colchicine	23	suppressed
Fluconazole	Fluconazole	23	suppressed
Metformin Hcl Er	Metformin Hcl	23	11
Ondansetron Hcl	Ondansetron Hcl	23	suppressed
Trulicity	Dulaglutide	23	suppressed
Famotidine	Famotidine	22	suppressed
Glimepiride	Glimepiride	22	suppressed
Memantine Hcl	Memantine Hcl	22	suppressed
Novolin N	Insulin Nph Human Isophane	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Cephalexin	Cephalexin	21	16
Diazepam	Diazepam	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Temazepam	Temazepam	21	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Meloxicam	Meloxicam	20	11
Primidone	Primidone	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Cholestyramine	Cholestyramine (With Sugar)	18	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	18	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	18	suppressed
Azithromycin	Azithromycin	17	17
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	11
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Ursodiol	Ursodiol	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Fluticasone Propionate	Fluticasone Propionate	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	14
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Insulin Aspart Flexpen	Insulin Aspart	14	suppressed
Novolin N Flexpen	Insulin Nph Human Isophane	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Torsemide	Torsemide	14	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Pen Needle	Pen Needle, Diabetic	13	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Clindamycin Hcl	Clindamycin Hcl	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Erythromycin	Erythromycin Base	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Nystatin	Nystatin	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error